Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Erratum: Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.

Ghosh M, Galman C, Rudling M, Angelin B.

J Lipid Res. 2018 Nov;59(11):2253. doi: 10.1194/jlr.M055780ERR. No abstract available.

2.

Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.

Al-Khaifi A, Straniero S, Voronova V, Chernikova D, Sokolov V, Kumar C, Angelin B, Rudling M.

J Intern Med. 2018 Nov;284(5):546-559. doi: 10.1111/joim.12811. Epub 2018 Jul 31.

PMID:
29964306
3.

An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers.

Al-Khaifi A, Rudling M, Angelin B.

Gastroenterology. 2018 Oct;155(4):1012-1016. doi: 10.1053/j.gastro.2018.06.038. Epub 2018 Jun 19.

4.

Unique case of cerebrotendinous xanthomatosis revisited: All the mutations responsible for this disease are present in the CYP27A1 gene.

Jiao H, Olin M, Hansson M, Eggertsen G, Eriksson M, Angelin B, Björkhem I.

J Intern Med. 2018 Jun;283(6):604-606. doi: 10.1111/joim.12709. Epub 2017 Nov 28. No abstract available.

PMID:
29095540
5.

Cholestyramine treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated.

Sjöberg BG, Straniero S, Angelin B, Rudling M.

Am J Physiol Endocrinol Metab. 2017 Aug 1;313(2):E167-E174. doi: 10.1152/ajpendo.00416.2016. Epub 2017 May 9.

6.

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Olsson AG, Angelin B, Assmann G, Binder CJ, Björkhem I, Cedazo-Minguez A, Cohen J, von Eckardstein A, Farinaro E, Müller-Wieland D, Parhofer KG, Parini P, Rosenson RS, Starup-Linde J, Tikkanen MJ, Yvan-Charvet L.

J Intern Med. 2017 Jun;281(6):534-553. doi: 10.1111/joim.12614. Review.

PMID:
28295777
7.

Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III.

Ghosh Laskar M, Eriksson M, Rudling M, Angelin B.

J Intern Med. 2017 Jun;281(6):575-585. doi: 10.1111/joim.12594. Epub 2017 Feb 1.

PMID:
28145001
8.

Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?

Bonde Y, Angelin B.

Trends Mol Med. 2017 Feb;23(2):97-99. doi: 10.1016/j.molmed.2016.12.006. Epub 2017 Jan 10.

PMID:
28082126
9.

Mental distress in treatment seeking young adults (18-25 years) with severe obesity compared with population controls of different body mass index levels: cohort study.

Dreber H, Reynisdottir S, Angelin B, Tynelius P, Rasmussen F, Hemmingsson E.

Clin Obes. 2017 Feb;7(1):1-10. doi: 10.1111/cob.12170. Epub 2017 Jan 6.

PMID:
28058812
10.

High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.

Frias MA, Thomas A, Brulhart-Meynet MC, Kövamees O, Pernow J, Eriksson M, Angelin B, James RW, Brinck JW.

Eur J Clin Invest. 2017 Jan;47(1):38-43. doi: 10.1111/eci.12699. Epub 2016 Nov 30.

PMID:
27861771
11.

Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report.

Apro J, Tietge UJ, Dikkers A, Parini P, Angelin B, Rudling M.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):787-91. doi: 10.1161/ATVBAHA.116.307385. Epub 2016 Mar 31.

12.

Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans.

Lehtihet M, Bonde Y, Beckman L, Berinder K, Hoybye C, Rudling M, Sloan JH, Konrad RJ, Angelin B.

PLoS One. 2016 Feb 11;11(2):e0148802. doi: 10.1371/journal.pone.0148802. eCollection 2016.

13.

Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels.

Kovamees O, Shemyakin A, Eriksson M, Angelin B, Pernow J.

J Intern Med. 2016 May;279(5):477-84. doi: 10.1111/joim.12461. Epub 2015 Dec 28.

14.

Who is the Treatment-Seeking Young Adult with Severe Obesity: A Comprehensive Characterization with Emphasis on Mental Health.

Dreber H, Reynisdottir S, Angelin B, Hemmingsson E.

PLoS One. 2015 Dec 22;10(12):e0145273. doi: 10.1371/journal.pone.0145273. eCollection 2015.

15.

Letter to the Editor: Potential Role for FGF21 as a Mediator of Thyroid Hormone Effects on Metabolic Regulation.

Bonde Y, Angelin B, Rudling M.

J Clin Endocrinol Metab. 2015 Dec;100(12):L130-1. doi: 10.1210/jc.2015-3548. No abstract available.

PMID:
26642273
16.

Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients.

Apro J, Parini P, Broijersén A, Angelin B, Rudling M.

J Lipid Res. 2015 Aug;56(8):1633-9. doi: 10.1194/jlr.P058842. Epub 2015 Jun 19.

17.

Influence of dietary sugar on cholesterol and bile acid metabolism in the rat: Marked reduction of hepatic Abcg5/8 expression following sucrose ingestion.

Apro J, Beckman L, Angelin B, Rudling M.

Biochem Biophys Res Commun. 2015 Jun 12;461(4):592-7. doi: 10.1016/j.bbrc.2015.04.070. Epub 2015 Apr 22.

PMID:
25912874
18.

Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.

Ghosh M, Gälman C, Rudling M, Angelin B.

J Lipid Res. 2015 Feb;56(2):463-9. doi: 10.1194/jlr.M055780. Epub 2014 Dec 22. Erratum in: J Lipid Res. 2018 Nov;59(11):2253.

19.

Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans.

Bonde Y, Breuer O, Lütjohann D, Sjöberg S, Angelin B, Rudling M.

J Lipid Res. 2014 Nov;55(11):2408-15. doi: 10.1194/jlr.M051664. Epub 2014 Aug 29.

20.

Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome.

Angelin B, Kristensen JD, Eriksson M, Carlsson B, Klein I, Olsson AG, Chester Ridgway E, Ladenson PW.

J Intern Med. 2015 Mar;277(3):331-342. doi: 10.1111/joim.12261. Epub 2014 May 16.

21.

Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans.

Lundberg J, Höybye C, Krusenstjerna-Hafstrøm T, Bina HA, Kharitonenkov A, Angelin B, Rudling M.

J Intern Med. 2013 Sep;274(3):227-32. doi: 10.1111/joim.12112. Epub 2013 Jul 24.

22.

Interstitial fluid lipoproteins.

Lundberg J, Rudling M, Angelin B.

Curr Opin Lipidol. 2013 Aug;24(4):327-31. doi: 10.1097/MOL.0b013e3283630846. Review.

PMID:
23803576
23.

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F.

Cell Metab. 2013 Feb 5;17(2):225-35. doi: 10.1016/j.cmet.2013.01.003.

24.

Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.

Angelin B, Larsson TE, Rudling M.

Cell Metab. 2012 Dec 5;16(6):693-705. doi: 10.1016/j.cmet.2012.11.001. Review.

25.

Fifty years of lipoprotein(a) -- the magical mystery tour continues.

Angelin B.

J Intern Med. 2013 Jan;273(1):3-5. doi: 10.1111/joim.12013. No abstract available.

26.

Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex.

Bonde Y, Plösch T, Kuipers F, Angelin B, Rudling M.

Hepatology. 2012 Nov;56(5):1828-37. doi: 10.1002/hep.25861. Epub 2012 Oct 14.

27.

Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration.

Troutt JS, Rudling M, Persson L, Ståhle L, Angelin B, Butterfield AM, Schade AE, Cao G, Konrad RJ.

Clin Chem. 2012 Aug;58(8):1225-32. doi: 10.1373/clinchem.2012.186866. Epub 2012 Jun 7.

28.

Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice.

Lundåsen T, Andersson EM, Snaith M, Lindmark H, Lundberg J, Östlund-Lindqvist AM, Angelin B, Rudling M.

PLoS One. 2012;7(5):e37787. doi: 10.1371/journal.pone.0037787. Epub 2012 May 25.

29.

Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women.

Persson L, Henriksson P, Westerlund E, Hovatta O, Angelin B, Rudling M.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):810-4. doi: 10.1161/ATVBAHA.111.242461. Epub 2011 Dec 29.

PMID:
22207727
30.

[Drilling-machines, quills--and artistic harmony].

Angelin B.

Lakartidningen. 2011 Oct 12-18;108(41):2040-2. Swedish. No abstract available.

PMID:
22111256
31.

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.

Gälman C, Angelin B, Rudling M.

J Intern Med. 2011 Dec;270(6):580-8. doi: 10.1111/j.1365-2796.2011.02466.x. Epub 2011 Nov 2.

32.

Lipid lowering with thyroid hormone and thyromimetics.

Angelin B, Rudling M.

Curr Opin Lipidol. 2010 Dec;21(6):499-506. doi: 10.1097/MOL.0b013e3283402e9c. Review.

PMID:
20935564
33.

Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.

Persson L, Cao G, Ståhle L, Sjöberg BG, Troutt JS, Konrad RJ, Gälman C, Wallén H, Eriksson M, Hafström I, Lind S, Dahlin M, Amark P, Angelin B, Rudling M.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2666-72. doi: 10.1161/ATVBAHA.110.214130. Epub 2010 Sep 30.

PMID:
20884874
34.

Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.

Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B.

N Engl J Med. 2010 Mar 11;362(10):906-16. doi: 10.1056/NEJMoa0905633.

35.

Control of ACAT2 liver expression by HNF4{alpha}: lesson from MODY1 patients.

Pramfalk C, Karlsson E, Groop L, Rudel LL, Angelin B, Eriksson M, Parini P.

Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1235-41. doi: 10.1161/ATVBAHA.109.188581. Epub 2009 May 28.

PMID:
19478207
36.

Is endometroid cancer of the ovaries a late manifestation of Alström syndrome?

Moberg E, Hjerpe E, Ehrsson RJ, Möller C, Angelin B.

J Intern Med. 2009 Feb;265(2):296-8. doi: 10.1111/j.1365-2796.2008.02003.x. No abstract available.

37.

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.

Hua X, Su J, Svenungsson E, Hurt-Camejo E, Jensen-Urstad K, Angelin B, Båvenholm P, Frostegård J.

Scand J Rheumatol. 2009 May-Jun;38(3):184-9. doi: 10.1080/03009740802541470.

PMID:
19165647
38.

Importance of proprotein convertase subtilisin/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors.

Persson L, Gälman C, Angelin B, Rudling M.

Endocrinology. 2009 Mar;150(3):1140-6. doi: 10.1210/en.2008-1281. Epub 2008 Nov 13.

PMID:
19008317
39.

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

Gälman C, Lundåsen T, Kharitonenkov A, Bina HA, Eriksson M, Hafström I, Dahlin M, Amark P, Angelin B, Rudling M.

Cell Metab. 2008 Aug;8(2):169-74. doi: 10.1016/j.cmet.2008.06.014.

40.

Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone.

Gälman C, Bonde Y, Matasconi M, Angelin B, Rudling M.

Gastroenterology. 2008 Apr;134(4):1127-36. doi: 10.1053/j.gastro.2008.01.032. Epub 2008 Jan 17.

PMID:
18395092
41.

Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.

Parini P, Gustafsson U, Davis MA, Larsson L, Einarsson C, Wilson M, Rudling M, Tomoda H, Omura S, Sahlin S, Angelin B, Rudel LL, Eriksson M.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1200-6. doi: 10.1161/ATVBAHA.107.157172. Epub 2008 Mar 13.

42.

The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.

Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD.

Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):663-7. Epub 2007 Dec 26.

43.

Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells.

Pramfalk C, Angelin B, Eriksson M, Parini P.

Biochem Biophys Res Commun. 2007 Dec 14;364(2):402-9. Epub 2007 Oct 15.

PMID:
17950700
44.

PPARalpha is a key regulator of hepatic FGF21.

Lundåsen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, Rudling M.

Biochem Biophys Res Commun. 2007 Aug 24;360(2):437-40. Epub 2007 Jun 21.

PMID:
17601491
45.

Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol.

Gälman C, Matasconi M, Persson L, Parini P, Angelin B, Rudling M.

Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E737-42. Epub 2007 Jun 19.

46.

Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression.

Nilsson LM, Abrahamsson A, Sahlin S, Gustafsson U, Angelin B, Parini P, Einarsson C.

Biochem Biophys Res Commun. 2007 Jun 8;357(3):707-11. Epub 2007 Apr 9.

PMID:
17448444
47.

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

Lundåsen T, Gälman C, Angelin B, Rudling M.

J Intern Med. 2006 Dec;260(6):530-6. Erratum in: J Intern Med. 2008 Apr;263(4):459.

48.

[The apoB/apoA-I ratio is better myocardial infarction marker than lipids].

Walldius G, Angelin B, Eriksson M.

Lakartidningen. 2006 Mar 8-14;103(10):751-2. Review. Swedish. No abstract available.

PMID:
16610201
49.

Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system.

Parini P, Johansson L, Bröijersén A, Angelin B, Rudling M.

Eur J Clin Invest. 2006 Feb;36(2):98-104.

PMID:
16436091
50.

Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis.

Gälman C, Angelin B, Rudling M.

Gastroenterology. 2005 Nov;129(5):1445-53.

PMID:
16285946

Supplemental Content

Loading ...
Support Center